8-K: SelectQuote Reports Strong FY25, Boosts FY26 Outlook

SelectQuote, Inc. announced robust fiscal year 2025 results, exceeding internal expectations for the third consecutive year, driven by significant growth in its Healthcare Services segment and a strengthened capital structure.

Summary

• Consolidated revenue for fiscal year 2025 increased by 15.5% to $1.527 billion, up from $1.322 billion in fiscal year 2024.
• Net income for fiscal year 2025 was $47.6 million, a significant improvement from a net loss of $34.1 million in fiscal year 2024.
• Adjusted EBITDA for fiscal year 2025 grew by 7.7% to $126 million, compared to $117 million in fiscal year 2024.
• The Healthcare Services segment saw revenue surge by 55.2% to $742.7 million in FY25, with Adjusted EBITDA increasing by 225% to $25.4 million.
• SelectRx members increased by 31% to 108,018 as of June 30, 2025, up from 82,385 in the prior year.
• The Senior segment's revenue decreased by 8.5% to $600.4 million in FY25, and its Adjusted EBITDA declined by 3.0% to $161.7 million.
• Approved Medicare Advantage policies in the Senior segment decreased by 5.2% to 592,874 in FY25.
• The Life segment's revenue increased by 9.5% to $173.0 million in FY25, with Adjusted EBITDA rising by 32.3% to $26.7 million.
• The company provided fiscal year 2026 guidance, projecting revenue between $1.650 billion and $1.750 billion, and Adjusted EBITDA between $120 million and $150 million.
• The capital structure was significantly improved through a securitization in October 2024 and a preferred equity investment in February 2025, leading to a $260 million repayment of term debt.
• Total debt was reduced from $683 million to $385 million, resulting in approximately $30 million in cumulative annual cash interest reduction and a 160 basis point decrease in blended cost of capital.

Sentiment

Score: 7

Explanation: The company reported strong overall financial performance for FY25, significantly improved net income, and robust growth in its strategic Healthcare Services segment. A substantial improvement in the capital structure, including debt reduction and lower interest costs, further strengthens its financial position. While the core Senior segment experienced declines, the positive FY26 guidance and management's consistent outperformance against internal forecasts indicate a positive trajectory and effective strategic execution.

Positives

• Consolidated net income significantly improved to $47.6 million in FY25 from a $34.1 million loss in FY24.
• Healthcare Services segment demonstrated exceptional growth, with revenue up 55.2% and Adjusted EBITDA up 225% in FY25.
• SelectRx membership increased by 31% year-over-year, indicating strong adoption of pharmacy services.
• The company successfully strengthened its capital structure, reducing total debt by $298 million and decreasing annual cash interest by approximately $30 million.
• Term debt maturity was extended to September 2027, enhancing financial flexibility.
• Achieved a 24% increase in year-over-year agent productivity in the Senior division.
• Revenue/Customer Acquisition Cost (CAC) multiple improved to 6.1X in FY25 from 4.5X in FY24, indicating more efficient customer acquisition.
• Management reported outperforming initial Adjusted EBITDA forecasts by over 20% for the third consecutive year.

Negatives

• Consolidated Adjusted EBITDA for the fourth quarter of fiscal year 2025 decreased significantly to $2.7 million from $14.4 million in the same period last year.
• The Senior segment experienced a revenue decline of 8.5% and a 3.0% decrease in Adjusted EBITDA for the full fiscal year 2025.
• Approved Medicare Advantage policies in the Senior segment decreased by 5.2% in FY25.
• Adjusted EBITDA per MA/MS policy decreased to $265 in FY25 from $279 in FY24.

Risks

• Reliance on a limited number of insurance carrier partners and potential termination of those relationships.
• Existing and future laws and regulations affecting the health insurance market.
• Changes in health insurance products offered by insurance carrier partners and the health insurance market generally.
• Competition from brokers, exclusively online brokers, and carriers selling directly to consumers.
• Dependence on revenue from the Senior segment and potential downturns in the senior health, life, automotive, and home insurance industries.
• Failure to enroll individuals during the Medicare annual enrollment period.
• Ability to attract, integrate, and retain qualified personnel.
• Dependence on lead providers and ability to compete for leads.
• Failure to obtain and/or convert sales leads to actual sales of insurance policies.
• Existing or potential litigation and other legal proceedings or inquiries, including a Department of Justice action alleging violations of the federal False Claims Act.
• Ability to maintain compliance with debt covenants.
• Fluctuations in financial results caused by seasonality.
• Disruptions or failures of technological infrastructure and platform.
• Cybersecurity breaches or other attacks involving systems or those of partners/providers.
• Factors related to the pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, contractual reimbursement rates, and regulatory changes.

Future Outlook

The company expects fiscal year 2026 revenue to be in the range of $1.650 billion to $1.750 billion, representing an 11% year-over-year increase at the midpoint. Adjusted EBITDA for fiscal year 2026 is projected to be between $120 million and $150 million, an increase of 7% year-over-year at the midpoint. Management anticipates continued value creation for stakeholders through its holistic healthcare services model and new growth initiatives.

Management Comments

• "The strength of our holistic healthcare services model was broadly exhibited in fiscal 2025, and we firmly believe the years ahead will increasingly drive substantial value for each of our stakeholders."
• "Policyholders and patients will continue to benefit from our information advantage through tailored advice and healthcare solutions, which ultimately result in better health outcomes."
• "Our insurance and healthcare service partners benefit from better treatment fit and adherence, which eliminates waste and serves to ease the historical trend of rising healthcare costs for Americans."
• "Additionally, we believe our shareholders will benefit as SelectQuotes diverse breadth of revenues drive increasing cash flow, which will accelerate and compound with new growth initiatives in the future."
• "We are proud to have delivered financial results well in excess of our initial expectations for the 3rd consecutive year. Over that period, our Adjusted EBITDA results have outperformed our forecasts by more than 20% each year."
• "Our leadership and workforce have accomplished these results through significant change in Medicare Advantage in each year. We credit the talent and hard work of our people and are exceedingly proud of the track record SelectQuote has built as an agile, innovative and reliable source of value for Americans seeking healthcare that best fits their needs."

Industry Context

The announcement highlights SelectQuote's strategic pivot towards a holistic healthcare services model, particularly through the rapid expansion of its Healthcare Services segment (SelectRx). This aligns with broader industry trends focusing on integrated care, patient adherence, and value-based healthcare solutions, aiming to address rising healthcare costs and improve patient outcomes. While the traditional Senior insurance segment faces competitive pressures and changes in the Medicare Advantage landscape, the company's diversified revenue streams and focus on technology-driven efficiency position it within the evolving healthcare and insurance brokerage sectors.

Comparison to Industry Standards

• No specific comparable companies, projects, or global benchmarks were mentioned in the filing for direct comparison.

Legal Proceedings

• Existing or potential litigation and other legal proceedings or inquiries, including the Department of Justice action alleging violations of the federal False Claims Act.

Stakeholder Impact

• Shareholders are expected to benefit from the company's diverse breadth of revenues, increasing cash flow, and new growth initiatives.
• Policyholders and patients will continue to benefit from tailored advice and healthcare solutions, leading to better health outcomes.
• Insurance and healthcare service partners benefit from better treatment fit and adherence, which aims to eliminate waste and ease rising healthcare costs.
• The workforce is credited for their talent and hard work in achieving financial results amidst changes in Medicare Advantage.

Next Steps

• Host a conference call with the investment community on August 21, 2025, at 8:30 a.m. ET to discuss the results.
• Continue to drive increasing cash flow through diverse revenue streams and accelerate new growth initiatives.
• Ongoing evaluation of options to further optimize capital structure and deliver value creation for shareholders.

Key Dates

Recommendation

The company has demonstrated consistent outperformance against its own forecasts, indicating strong operational execution and a reliable management team. The significant growth in the Healthcare Services segment, coupled with a substantially improved capital structure (reduced debt, lower interest costs, extended maturities), positions the company for future growth and enhanced financial stability. While the Senior segment faces headwinds, the strategic pivot towards a holistic healthcare services model and the positive FY26 guidance suggest a favorable long-term outlook for investors willing to embrace the strategic shift.

Keywords

Insurance, Medicare Advantage, Healthcare Services, SelectRx, Life Insurance, Financial Results, SEC Filing, Earnings, Adjusted EBITDA, Capital Structure